There is one resource available
Capmatinib in patient with astrocytoma grade 4 IDH mutation and MET exon 4 skipping mutation
Presenter: David Dufek
Session: YO Clinical Case Discussion
Resources:
Slides
Webcast
ESMO Sarcoma and Rare Cancers Congress 2024
14 - 16 Mar 2024
Lugano, Switzerland
Abstracts and ePosters: Open Access
Slides and Webcasts: Available to ESMO Members and registered delegates, subject to presenters' consent
The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties. ESMO thanks the authors for their generosity.
The Programme provided insights into the diagnosis, prognostication, management and ongoing research of patients with rare adult solid cancers. Educational and scientific sessions covered multidisciplinary expert management, targeted therapies, precision medicine, methodological challenges, policy and guidelines, as well as sessions specifically designed for young investigators.
All resources are published!
Use the search box below to type any keywords, or the abstract number.
Industry partners' Satellite Symposia
Servier - Search, find and rescue: Current science and future opportunities targeting IDH mutations in cancer
To access the other Industry Satellite Symposium that took place at the ESMO Sarcoma and Rare Cancers Congress 2024, take a look here
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.